Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where E. Patsouris is active.

Publication


Featured researches published by E. Patsouris.


Oral Oncology | 2009

Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer

Eleftherios Vairaktaris; Z. Serefoglou; Dimitris Avgoustidis; Christos Yapijakis; Elena Critselis; Antonis Vylliotis; Sofia Spyridonidou; Spyridoula Derka; Stavros Vassiliou; Emeka Nkenke; E. Patsouris

Genetic association studies have implicated functional DNA polymorphisms in genes encoding factors related to angiogenesis, inflammation and thrombosis with increased risk for oral squamous cell carcinoma (OSCC). This study examines possible interactions between nine such genotype polymorphisms and their combinatory effect in assessing the OSCC risk in a European population. OSCC cases (N=162) and healthy controls (N=168) of comparable age, gender, and ethnicity (Greeks and Germans) were studied. Multivariate logistic regression models were constructed in order to assess the contribution of homozygous or heterozygous variant genotypes of polymorphisms MMP-1 (-1607 1G/2G), MMP-3 (-1171 5A/6A), MMP-9 (-1562C/T), TIMP-2 (-418C/G), VEGF (+936C/T), GPI-alpha (+807C/T), PAI-1 (4G/5G), ACE (intron 16D/I) and TAFI (+325C/T) upon overall, early and advanced stages of OSCC. Four out of nine polymorphisms affecting PAI-1, MMP-9, TIMP-2 and ACE expression contributed significantly in OSCC prediction in the various logistic regression models. Based on these findings and previous reports, possible interactions of the implicated factors leading to OSCC development, as well as an algorithm of risk estimation are discussed.


Histopathology | 2003

Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival

A.E. Konstantinidou; Pinelopi Korkolopoulou; H Mahera; Xenophon Kotsiakis; S Hranioti; C. Eftychiadis; E. Patsouris

Aims:  A retrospective immunohistochemical and statistical analysis of patients with non‐malignant meningiomas was undertaken to determine the correlation of steroid hormone receptor status with apoptosis, tumour cell proliferation, clinicopathological characteristics and prediction of recurrence.


Journal of Plastic Reconstructive and Aesthetic Surgery | 2011

Improvement of skin-graft survival after autologous transplantation of adipose-derived stem cells in rats

A. Zografou; Christos Tsigris; Othon Papadopoulos; Nikolaos Kavantzas; E. Patsouris; Ismini Donta; Despina Perrea

BACKGROUND Skin grafts are frequently used for a variety of indications in plastic and reconstructive surgery. Their necrosis is a common complication, while different therapies have been proposed. Currently, adipose-derived stem cells (ASCs) hold great promise for their angiogenic potential and role during tissue repair. In this study, autologous transplantation of ASCs was used in skin grafts in rats to determine if it increases angiogenesis, skin-graft survival and wound healing. METHODS ASCs were isolated, cultured, labelled with fluorescent dye and injected under full-thickness skin grafts in 10 rats (group 1), while 10 others served as controls (group 2). Skin grafts were analysed after 1 week. Collagens framework was assessed with Massons trichrome stain and angiogenesis with von Willebrand factor (vWF) immunohistochemistry. In addition, immunohistochemical staining intensity of vascular endothelial growth factor (VEGF) and transforming growth factor b3 (TGFb3) was assessed in all grafts. RESULTS Mean area of graft necrosis was significantly less in group 1 than in group 2 (6.12% vs. 32.62%, p<0.01). Statistically significant increase of microvessel density, collagen density, VEGF and TGFb3 expression was noted in group 1 compared with group 2 (all: p<0.01). CONCLUSIONS These findings suggest that autologous ASCs transplantation increases full-thickness skin-graft survival and shows promise for use in skin-graft surgery. This might be both due to in situ differentiation of ASCs into endothelial cells and increased secretion by ASCs of growth factors, such as VEGF and TGFb3 that enhance angiogenesis and wound healing.


International Journal of Biological Markers | 2006

Strong association of interleukin-6 -174 G>C promoter polymorphism with increased risk of oral cancer.

Eleftherios Vairaktaris; A. Yiannopoulos; Antonis Vylliotis; Christos Yapijakis; Spyridoula Derka; Stavros Vassiliou; E. Nkenke; Z. Serefoglou; Vassilis Ragos; Christos Tsigris; Eleni Vorris; Elena Critselis; Dimitris Avgoustidis; F.W. Neukam; E. Patsouris

In view of the recently found contribution of factors associated with thrombosis and inflammation to carcinogenesis, we investigated the possible association of interleukin-6 (IL-6) with an increased risk of oral cancer. In DNA samples of 162 patients with oral squamous cell carcinoma and 156 healthy controls of comparable ethnicity, age and sex, we studied the -174 G>C polymorphism in the IL-6 gene, which affects its transcription. C allele frequencies were significantly increased in patients compared to controls, 42.6% versus 23.1% (p<0.001). The CC homozygotes had a 7-fold greater risk of developing oral cancer (odds ratio 7.39, 95% CI 2.61-20.92), while the GC heterozygotes had a 4-fold greater risk (odds ratio 3.74, 95% CI 2.29-6.11). A significant increase in C alleles was observed in patients regardless of their smoking or alcohol consumption habits, early or advanced stage of cancer, and presence or absence of a family history for cancer or thrombophilia (p<0.001; Fishers exact test). These findings suggest that the -174 G>C polymorphism, by affecting IL-6 gene expression, is strongly associated with oral oncogenesis.


Journal of the American College of Cardiology | 2008

In Vivo Aortic Valve Thermal Heterogeneity in Patients With Nonrheumatic Aortic Valve Stenosis: The First In Vivo Experience in Humans

Konstantinos Toutouzas; Maria Drakopoulou; Andreas Synetos; Eleftherios Tsiamis; George Agrogiannis; Nikolaos Kavantzas; E. Patsouris; Dimitris Iliopoulos; Stergios Theodoropoulos; Magdi H. Yacoub; Christodoulos Stefanadis

OBJECTIVES We investigated in vivo in aortic valve stenosis (AVS) whether there is: 1) thermal heterogeneity within the valve leaflets; 2) temperature difference between the leaflets and the ascending aortic wall; and 3) a possible correlation between heat production, inflammation, and neoangiogenesis. BACKGROUND Histological studies have demonstrated a potential role of inflammation and neoangiogenesis in AVS. METHODS We examined 96 leaflets scheduled for aortic valve replacement. Twenty-five patients had AVS, and 7 had aortic valve insufficiency (AVI). Temperature measurements were performed right before hypothermic cardioplegia. Temperature difference (DeltaT) was assigned as the mean temperature of each leaflet minus the temperature of the aortic wall. Histological, immunohistological analysis, and vascular endothelial growth factor (VEGF) immunoreactivity was performed. RESULTS Significant thermal heterogeneity was recorded within the leaflets of AVS, compared with AVI (1.52 +/- 1.35 degrees C vs. 0.13 +/- 0.11 degrees C, p < 0.01). In AVS DeltaT was greater in all leaflets compared with the AVI group (p < 0.01). Leaflets of AVS had increased inflammatory cell infiltration, calcium deposit, and anti-VEGF expression compared with AVI (p < 0.01). CONCLUSIONS Thermal heterogeneity is increased in AVS and correlates with inflammatory mononuclear cell infiltration, expression of pro-inflammatory cytokines and neoangiogenic factors.


Histopathology | 1998

Prognostic relevance of apoptotic cell death in non‐Hodgkin's lymphomas: a multivariate survival analysis including Ki67 and p53 oncoprotein expression

Pinelopi Korkolopoulou; M K Angelopoulou; F Kontopidou; A Tsenga; E. Patsouris; E Thomas-Tsagli; Christos Kittas; G A Pangalis

Aims: To evaluate the independent prognostic value of apoptotic versus proliferative fractions in a series of 92 patients with non‐Hodgkins lymphomas (NHL).


Annals of Neurology | 2001

Increased incidence of sporadic Creutzfeldt-Jakob disease on the island of Crete associated with a high rate of PRNP 129-methionine homozygosity in the local population.

Andreas Plaitakis; Anna K. Viskadouraki; Minas Tzagournissakis; Ioannis Zaganas; Susan Verghese-Nikolakaki; Vasilis Karagiorgis; Ioannis Panagiotides; Constantine Kilindireas; E. Patsouris; Christine Haberler; Herbert Budka; Theodoros Sklaviadis

Since the spring of 1997, when the Neurology Department of the University Hospital of Crete admitted its first patient, 9 cases (8 neuropathologically confirmed and 1 probable) of sporadic Creutzfeldt‐Jakob disease (sCJD) have been recorded. This represents an annual incidence five‐fold higher than expected based on the islands population (0.54 million). Molecular analysis of the prion‐protein gene (PRNP) showed no mutations in any of the seven CJD cases studied. Five patients (ages 64–88 years) were homozygous for methionine‐129 of PRNP and showed the classic sCJD triad (subacute dementia, myoclonus, periodic electroencephalogram). Brains contained Type 1 (unglycosylated 21.5 kDa band) protease‐resistant prion protein (PrPres). Two patients (ages 56 and 57 years), both homozygous for valine‐129, showed cerebellar ataxia and later dementia not associated with periodic electroencephalogram; brain PrPres was Type 2. Genotyping of 205 Cretan controls showed that methionine‐129 homozygosity, a susceptibility factor for sCJD, was significantly higher in this population than in other Caucasian populations (57.0%, n = 205 versus 41.5%, n = 859. These data are the first to relate a high regional incidence rate for sCJD to the distribution of PRNP 129 genotypes in the local population; however, additional factors may be operational.


Pathology | 2011

Loss of E-cadherin independently predicts the lymph node status in colorectal cancer

Eva Karamitopoulou; Inti Zlobec; E. Patsouris; George Peros; Alessandro Lugli

Background: The identification of biomarkers that improve risk stratification in patients with colorectal cancer (CRC) is still a challenge. The objective of our study was to identify independent protein markers as predictors of lymph node (N) stage in CRC. Methods: Tumour specimens from 221 CRC patients were mounted onto a multiple-punch tissue microarray and evaluated for 21 tumour related factors and one host related factor involved in CRC carcinogenesis, namely β-catenin, E-cadherin, EGFR, pERK, RHAMM, pAKT, pSMAD2, p21, p16, Bcl-2, Ki-67, APAF-1, MST1, RKIP, VEGF, EphB2, MMP7, Laminin5γ2, MUC1, CDX2, caspase-3 as well as intra-tumoural and stromal CD8+ tumour infiltrating lymphocytes (iTILs and sTILs). Results: Node positive cancers showed significant losses for p21 (p = 0.026), Bcl-2 (p = 0.027), APAF-1 (p = 0.033), EphB2 (p = 0.006), E-cadherin (p < 0.001), RKIP (p = 0.019), CD8+ iTILs and sTILs (p < 0.001 and p = 0.008, respectively) and cytoplasmic MST1 (p = 0.014). Based on the area under the receiver operating characteristic curve (AUC) EphB2, E-cadherin, iTILs and sTILs were identified as potential predictors of N stage (AUC values >0.6), but only loss of E-cadherin was an independent predictor in multivariate analysis. Conclusions: E-cadherin appears to be a strong predictor of N stage in CRC and should be considered in pre-operative and post-operative management of colon and rectal cancer patients.


Apoptosis | 2002

Apoptotic markers for tumor recurrence: a minireview.

A.E. Konstantinidou; Pinelopi Korkolopoulou; E. Patsouris

The control of apoptotic mechanisms is integral to many aspects of tumor biology and appears to be involved in the process of recurrence. Apoptosis serves as an essential mechanism to prevent the proliferation of cells with a higher mutation rate, thus tempering malignant transformation. Most antineoplastic therapies function by triggering apoptosis in sensitive cells. Resistance to treatment may result from specific inhibition of apoptotic signaling. Chemotherapy or radiation may increase the mutation rate and hasten tumor evolution in cancer cells that are resistant to apoptosis. Summarizing the current evidence regarding the usefulness of various apoptotic markers for predicting tumor recurrence, the most extensively studied appear to be bcl-2 and p53, as well as the apoptotic rate itself, with promising prognostic potential in several neoplasias. Investigative results, however, mostly refer to multiple single-center retrospective studies, awaiting validation by large prospective clinical trials. Despite initial optimism, it becomes apparent that the measurement of one or more gene products is inadequate to directly predict a phenomenon as complex as the clinical outcome. One of the challenges that is only beginning to be addressed is the combined assessment of traditional prognostic parameters and molecular biomarkers by creating models or equations to predict the likelihood of recurrence. Such screening of patients may help define prognostic categories and influence treatment decisions.


Pathology Research and Practice | 2012

pERK activation in esophageal carcinomas: Clinicopathological associations

K.E. Tasioudi; Angelica A. Saetta; Stratigoula Sakellariou; Georgia Levidou; Nikolaos V. Michalopoulos; Dimitrios Theodorou; E. Patsouris; Penelope Korkolopoulou

MAPK (mitogen-activated protein kinase) pathway is considered a control regulator in various malignant tumors but its role in esophageal carcinomas remains elusive. In our study, we examined the possible prognostic significance of MAPK pathway in human esophageal cancer. We searched for mutations in exons 18-21 of EGFR gene, codons 12 and 13 of K-RAS gene and exon 15 of B-RAF gene by high resolution melting analysis (HRMA) and pyrosequencing in 44 esophageal carcinomas. Immunohistochemistry was performed in 29 cases in order to evaluate expression levels of pERK (extracellular-signal regulated kinase). In one laser microdissected squamous cell carcinoma, a somatic K-RAS mutation at codon 12 was detected, whereas none of the cases displayed mutations in EGFR and B-RAF genes. Elevated nuclear as well as cytoplasmic pERK expression (100% and 62% of cases respectively) was observed independently of EGFR and B-RAF mutational status. Increasing pERK nuclear and cytoplasmic expression as well as the intensity of nuclear staining was found to be significantly correlated with tumor grade in univariate and multivariate statistical analysis. Our findings depict the presence of activated ERK despite the low frequency of upstream alterations, implicating ERK activation in the acquisition of a more aggressive phenotype in esophageal cancer.

Collaboration


Dive into the E. Patsouris's collaboration.

Top Co-Authors

Avatar

Andreas C. Lazaris

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Eleftherios Vairaktaris

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Christos Yapijakis

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Stavros Vassiliou

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Antonis Vylliotis

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Nikolaos Kavantzas

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Spyridoula Derka

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

A.E. Konstantinidou

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Emeka Nkenke

University of Erlangen-Nuremberg

View shared research outputs
Top Co-Authors

Avatar

Penelope Korkolopoulou

National and Kapodistrian University of Athens

View shared research outputs
Researchain Logo
Decentralizing Knowledge